Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia.

Description

Heterozygous familial hypercholesterolemia (HeFH) is increasingly better diagnosed and treatments can improve the cardiovascular prognosis. We evaluated the long-term cardiovascular risk of HeFH using the French REgistry of Familial hypERCHOLesterolemia (REFERCHOL).